Press release
Eosinophilic Gastroenteritis Market is valued at around USD 160 million in 2024 and is projected to reach approximately USD 290 million by 2034
Eosinophilic Gastroenteritis Market
The Eosinophilic Gastroenteritis (EGE) Market is valued at around USD 160 million in 2024 and is projected to reach approximately USD 290 million by 2034, registering a CAGR of about 6.1%. Growth is supported by increasing diagnosis rates, expanding awareness of eosinophilic gastrointestinal disorders, and improved imaging and biopsy-based testing.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71136
Key Market Drivers
• Increasing incidence of allergic and immune-mediated gastrointestinal conditions.
• Greater availability of endoscopic biopsy and histopathology enabling accurate diagnosis.
• Higher adoption of corticosteroids, biologics, and dietary management therapies.
• Rising awareness among gastroenterologists and patients.
Challenges
• Underdiagnosis due to overlapping symptoms with other GI disorders.
• Limited availability of approved targeted therapies.
• Variability in diagnostic criteria and treatment approaches across regions.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71136/eosinophilic-gastroenteritis-market
Market Segmentation
By Treatment
• Corticosteroids
• Biologics (anti-IL-5, anti-IgE agents)
• Proton pump inhibitors
• Dietary therapy (elimination diet)
• Immunomodulators
By Disease Type
• Mucosal
• Muscular
• Serosal
By Diagnosis
• Endoscopy
• Imaging
• Biopsy & histology
• Laboratory evaluation
By End User
• Hospitals
• Gastroenterology clinics
• Specialty allergy/immune disorder centers
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71136
Regional Snapshot
• North America dominates due to advanced diagnostic capabilities and higher awareness of EGIDs.
• Europe shows steady growth supported by clinical guidelines and wider use of biologic treatments.
• Asia-Pacific is expanding quickly as allergy-related GI disorders rise and healthcare access improves.
Key Companies
Sanofi, GlaxoSmithKline, AstraZeneca, Dr. Reddy's Laboratories, Teva Pharmaceuticals, Takeda, Ferring Pharmaceuticals.
This report is also available in the following languages : Japanese (好酸球性胃腸炎市場), Korean (호산구성 위장염 시장), Chinese (嗜酸性粒细胞性胃肠炎市场), French (Marché de la gastro-entérite à éosinophiles), German (Markt für eosinophile Gastroenteritis), and Italian (Mercato della gastroenterite eosinofila), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71136
Our More Reports:
Pharyngoscopes Market
https://exactitudeconsultancy.com/reports/70768/pharyngoscopes-market
Rhinometry Systems Market
https://exactitudeconsultancy.com/reports/70770/rhinometry-systems-market
Sinuscope Market
https://exactitudeconsultancy.com/reports/70772/sinuscope-market
Voice Prosthesis Devices Market
https://exactitudeconsultancy.com/reports/70774/voice-prosthesis-devices-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eosinophilic Gastroenteritis Market is valued at around USD 160 million in 2024 and is projected to reach approximately USD 290 million by 2034 here
News-ID: 4311729 • Views: …
More Releases from Exactitude Consultancy
Body Contouring Devices Market is projected to reach USD 16.04 billion by 2034
The global Body Contouring Devices Market was valued at USD 7.28 billion in 2024 and is projected to reach USD 16.04 billion by 2034, growing at a CAGR of 8.3% during 2025-2034. Growth is driven by rising demand for minimally invasive cosmetic procedures, growing global obesity rates, increasing aesthetic awareness, and expanding medical spa and dermatology clinic networks.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70968
Body contouring devices are…
Chronic Idiopathic Constipation (CIC) Market was valued at USD 8.2 billion in 20 …
Chronic Idiopathic Constipation (CIC) Market
The Chronic Idiopathic Constipation (CIC) Market was valued at USD 8.2 billion in 2024 and is projected to reach USD 12.9 billion by 2034, growing at a CAGR of around 4.8%. Growth is driven by rising gastrointestinal disorders, aging population, lifestyle factors, and wider adoption of prescription CIC therapies.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71132
Key Market Drivers
• Increasing prevalence of lifestyle-related constipation and sedentary…
Symptomatic Partial-Thickness Rotator Cuff Tears Market is projected to reach US …
The global Symptomatic Partial-Thickness Rotator Cuff Tears (PTRCT) Market was valued at USD 1.64 billion in 2024 and is projected to reach USD 2.95 billion by 2034, growing at a CAGR of 6.1% during 2025-2034. Market expansion is driven by rising sports injuries, increasing prevalence of degenerative shoulder conditions in aging populations, advancements in minimally invasive arthroscopy, and growing adoption of regenerative biologics such as PRP and stem-cell therapies.
Download Full…
Chronic Pancreatitis Market Growing at a CAGR of around 5.6%
Chronic Pancreatitis Market Overview
The Chronic Pancreatitis Market was valued at ~USD 5.1 billion in 2024 and is projected to reach ~USD 8.7 billion by 2034, growing at a CAGR of around 5.6%. Growth is driven by increasing cases of alcohol-related pancreatic injury, lifestyle changes, rising smoking prevalence, and growing demand for enzyme replacement therapies.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71134
Key Market Drivers
• Rising global incidence of alcohol-induced and…
More Releases for Gastroenteritis
Rising Incidence Of Bacterial Infections Drives Growth In The Gastroenteritis Te …
The Gastroenteritis Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Gastroenteritis Testing Market Size and Projected Growth Rate?
Recent years have witnessed significant expansion in the market size of gastroenteritis testing. It is projected to escalade from $3.94 billion in 2024 to…
Key Influencer in the Gastroenteritis Testing Market 2025: Rising Incidence Of B …
What market dynamics are playing a key role in accelerating the growth of the gastroenteritis testing market?
The increase in bacterial infections is projected to fuel the expansion of the gastroenteritis testing market. A surge in antibiotic resistance, heightened population density, and more global travel are contributing to the proliferation of these resistant bacteria. Accurate identification of the bacteria causing symptoms such as diarrhea and vomiting, is crucial and can be…
Leading Growth Driver in the Gastroenteritis Testing Market in 2025: Rising Inci …
What Are the Market Size and Growth Forecast for the Gastroenteritis Testing Market?
In recent times, there has been a solid growth in the market size of gastroenteritis testing. The forecast predicts that it will escalate from $3.94 billion in 2024 to $4.18 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.2%. The past growth is correlated with the increase in worldwide travel, population surge, rise in incidents…
Viral Gastroenteritis Market: Steady Growth, Rising Prevalence, and Emerging Tre …
Steady expansion of the viral gastroenteritis market is expected, driven by prevalence of viral infections, advancements in diagnostics, and pivotal trends such as vaccine development and digital health solutions.
What Is The Projected Market Size Of The Global Viral Gastroenteritis Market And Its Growth Rate?
The viral gastroenteritis market has been experiencing steady growth over the recent years:
• Projected Market Size in 2025: $7.08 billion
• Compound Annual Growth Rate (CAGR) of 2024-2025:…
Viral Gastroenteritis Market Share, Statistics, Trends And Forecast To 2033
The Business Research Company recently released a comprehensive report on the Global Viral Gastroenteritis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Market Dynamics and Growth Opportunities in Gastroenteritis Testing: 2024-2031 F …
The Gastroenteritis Testing Market sector is undergoing significant transformation, with substantial growth and technological advancements expected by 2031. According to a new in-depth market research report, the sector is poised for expansion, driven by various factors such as market size, share, and emerging trends.
This comprehensive report provides key insights into the Gastroenteritis Testing market, exploring critical market segmentation and definitions. It highlights the essential components driving growth, offering a clear…
